Morgan Stanley’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,795
| Closed | -$31.2K | – | 8200 |
|
|
2025
Q1 | $31.2K | Hold |
37,795
| – | – | ﹤0.01% | 6424 |
|
|
2024
Q4 | $35.9K | Hold |
37,795
| – | – | ﹤0.01% | 6389 |
|
|
2024
Q3 | $37.8K | Sell |
37,795
-42
| -0.1% | -$42 | ﹤0.01% | 6292 |
|
|
2024
Q2 | $46.9K | Hold |
37,837
| – | – | ﹤0.01% | 6198 |
|
|
2024
Q1 | $49.2K | Sell |
37,837
-39,237
| -51% | -$51K | ﹤0.01% | 6218 |
|
|
2023
Q4 | $96.3K | Buy |
77,074
+34,380
| +81% | +$43K | ﹤0.01% | 6176 |
|
|
2023
Q3 | $55.5K | Sell |
42,694
-52,394
| -55% | -$68.1K | ﹤0.01% | 6123 |
|
|
2023
Q2 | $164K | Sell |
95,088
-417,011
| -81% | -$717K | ﹤0.01% | 5730 |
|
|
2023
Q1 | $748K | Buy |
512,099
+52,432
| +11% | +$76.6K | ﹤0.01% | 5031 |
|
|
2022
Q4 | $745K | Buy |
459,667
+214,017
| +87% | +$347K | ﹤0.01% | 5032 |
|
|
2022
Q3 | $822K | Buy |
245,650
+31,854
| +15% | +$107K | ﹤0.01% | 4995 |
|
|
2022
Q2 | $778K | Buy |
213,796
+5,807
| +3% | +$21.1K | ﹤0.01% | 5177 |
|
|
2022
Q1 | $1.5M | Buy |
207,989
+6,827
| +3% | +$49.4K | ﹤0.01% | 4722 |
|
|
2021
Q4 | $2.73M | Buy |
201,162
+65,522
| +48% | +$890K | ﹤0.01% | 4322 |
|
|
2021
Q3 | $2.84M | Sell |
135,640
-36,733
| -21% | -$769K | ﹤0.01% | 4279 |
|
|
2021
Q2 | $4.13M | Buy |
172,373
+70,593
| +69% | +$1.69M | ﹤0.01% | 3981 |
|
|
2021
Q1 | $2.98M | Sell |
101,780
-10,032
| -9% | -$294K | ﹤0.01% | 3933 |
|
|
2020
Q4 | $3.34M | Buy |
+111,812
| New | +$3.34M | ﹤0.01% | 3700 |
|